Mental Health of Older Adults and Dementia
Services for the mental health of older adults and dementia (MHOAD) Clinical Academic Group (CAG) are managed within the Psychological Medicine and Older Adults Directorate. We offer a range of community and hospital based mental health services covering the London boroughs of Croydon, Lambeth, Lewisham and Southwark.
These include Community Mental Health Teams, Care Home Intervention Teams, memory services, psychology and psychotherapy services, home treatment teams, inpatient care, specialist care, and liaison services.
The CAG provides a range of education and training programmes, including a Band 7 development programme, medications management training for inpatient, specialist care and community staff, and simulation training.
We've also developed an online training platform with materials to support good practice in dementia and psychosis in later life called the Dementia Training Centre.
Key education achievements include:
- New e-learning course on recovery focused practice in older people’s services on the Dementia Training Centre.
The CAG has world leading researchers in Parkinson's disease dementia/Dementia with Lewy bodies, the global epidemiology of older people’s mental health problems and the use of clinical informatics to inform research and service development.
We have a full time specialist MHOAD pharmacist who has led work on developing a simple tool, the Anticholinergic Effect on Cognition score (AEC) for determining the cognitive side effects of physical health medications.
We are leading publicly funded randomised clinical trials and have a programme to improve recruitment of our Memory Service patients into clinical trials to develop and improve treatment for older patients with mental health difficulties and dementia, in line with the Government’s Dementia Challenge.
Our work in dementia has identified novel biomarkers for diagnosis and progression monitoring, new treatment and effectiveness trials, for example developing new magnetic resonance imaging (MRI) markers based on the shape of the hippocampus to confirm diagnosis of Alzheimer’s disease at the earliest stage, and trialling potential course-modifying drugs in patients within our memory services.